OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Neurodevelopmental Disorders is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Early life stress and development: potential mechanisms for adverse outcomes	195
Controlling litter effects to enhance rigor and reproducibility with rodent models of neurodevelopmental disorders	59
Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications	48
Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium	45
Pre-symptomatic intervention for autism spectrum disorder (ASD): defining a research agenda	38
Behavioural and psychological features of PTEN mutations: a systematic review of the literature and meta-analysis of the prevalence of autism spectrum disorder characteristics	35
Behavioural and neural markers of tactile sensory processing in infants at elevated likelihood of autism spectrum disorder and/or attention deficit hyperactivity disorder	34
Resting state EEG in youth with ASD: age, sex, and relation to phenotype	32
FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring	31
The prevalence and profile of autism in individuals born preterm: a systematic review and meta-analysis	30
Translational outcomes relevant to neurodevelopmental disorders following early life exposure of rats to chlorpyrifos	29
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder	28
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder	27
Risk of neurodevelopmental disorders in children born from different ART treatments: a systematic review and meta-analysis	26
Neurodevelopmental and psychiatric disorders in females with Turner syndrome: a population-based study	25
Feasibility of delivering parent-implemented NDBI interventions in low-resource regions: a pilot randomized controlled study	25
Maternal immune response and air pollution exposure during pregnancy: insights from the Early Markers for Autism (EMA) study	25
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)	24
Characterisation of the clinical phenotype in Phelan-McDermid syndrome	21
Utilization of telemedicine to support caregivers of young children with ASD and their Part C service providers: a comparison of intervention outcomes across three models of service delivery	21
Capturing cognitive and behavioral variability among individuals with Down syndrome: a latent profile analysis	21
Anxiety-like behavior and anxiolytic treatment in the Rett syndrome natural history study	21
Telehealth-enabled behavioral treatment for problem behaviors in boys with fragile X syndrome: a randomized controlled trial	21
Prediction of autism spectrum disorder diagnosis using nonlinear measures of language-related EEG at 6 and 12 months	21
Associations between sensory processing and electrophysiological and neurochemical measures in children with ASD: an EEG-MRS study	20

The electroretinogram b-wave amplitude: a differential physiological measure for Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder	20
Intellectual abilities, language comprehension, speech, and motor function in children with spinal muscular atrophy type 1	19
A small-molecule screen reveals novel modulators of MeCP2 and X-chromosome inactivation maintenance	19
Biomarkers for autism spectrum disorder: opportunities for magnetoencephalography (MEG)	18
Longitudinal change in restricted and repetitive behaviors from 8-36 months	18
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome	18
Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language	18
Bringing machine learning to research on intellectual and developmental disabilities: taking inspiration from neurological diseases	17
An electronic health record (EHR) phenotype algorithm to identify patients with attention deficit hyperactivity disorders (ADHD) and psychiatric comorbidities	17
Reflections on the genetics-first approach to advancements in molecular genetic and neurobiological research on neurodevelopmental disorders	17
mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus	17
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group	16
Affective and psychotic reactivity to daily-life stress in adults with 22q11DS: a study using the experience sampling method	16
Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I	15
Social cognition in 22q11.2 deletion syndrome and idiopathic developmental neuropsychiatric disorders	15
Trajectories of imitation skills in preschoolers with autism spectrum disorders	15
A multi-study examination of the role of repeated spaced retrieval in the word learning of children with developmental language disorder	14
Evidence for decreased parasympathetic response to a novel peer interaction in older children with autism spectrum disorder: a case-control study	14
The diagnostic journey of genetically defined neurodevelopmental disorders	14
Focus on your locus with a massively parallel reporter assay	14
Childhood infections and autism spectrum disorders and/or intellectual disability: a register-based cohort study	13
Oxidative stress indices in ASD children in Sub-Sahara Africa	13
Autism spectrum disorder in females with fragile X syndrome: a systematic review and meta-analysis of prevalence	13
Visual and somatosensory feedback mechanisms of precision manual motor control in autism spectrum disorder	13
Clinical and behavioural features of SYNGAP1-related intellectual disability: a parent and caregiver description	13
EEG resting-state functional connectivity: evidence for an imbalance of external/internal information integration in autism	13
Early behavioral and physiological markers of social anxiety in infants with fragile X syndrome	12
The importance of deep speech phenotyping for neurodevelopmental and genetic disorders: a conceptual review	12
Predicting progress in word learning for children with autism and minimal verbal skills	12
Long-term follow-up of a randomized controlled trial of choline for neurodevelopment in fetal alcohol spectrum disorder: corpus callosum white matter microstructure and neurocognitive outcomes	12
The research landscape of tuberous sclerosis complex–associated neuropsychiatric disorders (TAND)—a comprehensive scoping review	11
Comparison of resting-state EEG between adults with Down syndrome and typically developing controls	11
Development of an adapted Clinical Global Impression scale for use in Angelman syndrome	11
Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome	10
Copy number variation at the 22q11.2 locus influences prevalence, severity, and psychiatric impact of sleep disturbance	10
Developmental exposure to diesel exhaust upregulates transcription factor expression, decreases hippocampal neurogenesis, and alters cortical lamina organization: relevance to neurodevelopmental disor	10
The gut-microbiota-brain axis in autism: what Drosophila models can offer?	10
Parahippocampal deactivation and hyperactivation of central executive, saliency and social cognition networks in autism spectrum disorder	10
Cerebral cortex and blood transcriptome changes in mouse neonates prenatally exposed to air pollution particulate matter	10
White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics study	9
Self-reported psychological disorders among the mothers of children with autism spectrum disorder, type 1 diabetes mellitus, and typically developed children	9
Baclofen-associated neurophysiologic target engagement across species in fragile X syndrome	9
Increased 2-arachidonoyl-sn-glycerol levels normalize cortical responses to sound and improve behaviors in Fmr1 KO mice	9
Co-occurring hydrocephalus in autism spectrum disorder: a Danish population-based cohort study	9